Gastroenteritis and colitis due to radiation
Methodology & AI Transparency ⓘ
Gastroenteritis and colitis due to radiation Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as K52.0, Gastroenteritis and colitis due to radiation falls under IBS, IBD & Colon management, where age/symptom-appropriate colonoscopy or in Gastroenteritis and colitis due to radiation (K52.0: mucosal biopsy) establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Clinical coding for Gastroenteritis and colitis due to radiation uses ICD-10 K52.0 across IBS, IBD & Colon specialty care.
- 3 Typical cash cost range: Primary evaluation for Gastroenteritis and colitis due to radiation incorporates age/symptom-appropriate colonoscopy or in Gastroenteritis and colitis due to radiation (K52.0: mucosal biopsy) and symptom diary review.
- 4 Top reported side effects / signs: Follow-up benchmark in Gastroenteritis and colitis due to radiation: maintaining hs-CRP, CBC & in Gastroenteritis and colitis due to radiation (K52.0: Ferritin) within Normal hemoglobin; hs-CRP < 1.0 mg/L (K52.0).
Ask our AI Specialists anything about Gastroenteritis and colitis due to radiation
What Is Gastroenteritis and colitis due to radiation?
Designated in federal medical registries as K52.0, Gastroenteritis and colitis due to radiation falls under IBS, IBD & Colon management, where age/symptom-appropriate colonoscopy or in Gastroenteritis and colitis due to radiation (K52.0: mucosal biopsy) establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Gastroenteritis and colitis due to radiation (code K52.0) is mucosal tight-junction permeability in Gastroenteritis and colitis due to radiation (K52.0: shifts or immune-mediated), which IBS, Crohn, Colitis & Bowel Disorders clinicians address while surveilling hs-CRP, CBC & in Gastroenteritis and colitis due to radiation (K52.0: Ferritin) (Normal hemoglobin; hs-CRP < 1.0 mg/L (K52.0)).
Common Symptoms & Clinical Signs
- • Presentation of Gastroenteritis and colitis due to radiation (K52.0): rectal bleeding, nocturnal in Gastroenteritis and colitis due to radiation (K52.0: bowel movements, or)
- • Secondary Gastroenteritis and colitis due to radiation clinical sign: recurrent lower abdominal in Gastroenteritis and colitis due to radiation (K52.0: cramping associated with)
- • Symptom flares in Gastroenteritis and colitis due to radiation correlating with hs-CRP, CBC & in Gastroenteritis and colitis due to radiation (K52.0: Ferritin) deviation outside Normal hemoglobin; hs-CRP < 1.0 mg/L (K52.0)
- • Functional ibs, ibd & colon impact requiring age/symptom-appropriate colonoscopy or in Gastroenteritis and colitis due to radiation (K52.0: mucosal biopsy) evaluation (K52.0)
Gastroenteritis and colitis due to radiation Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K52.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | IBS, Crohn, Colitis & Bowel Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: hs-CRP, CBC & in Gastroenteritis and colitis due to radiation (K52.0: Ferritin) | Normal hemoglobin; hs-CRP < 1.0 mg/L (K52.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fecal Calprotectin [Gastroenteritis and colitis due to radiation K52.0] | < 50 mcg/g (K52.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Tissue Transglutaminase IgA in Gastroenteritis and colitis due to radiation (K52.0: (tTG-IgA)) | Negative (celiac rule-out) (K52.0) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Gastroenteritis and colitis due to radiation
Treatment selection for Gastroenteritis and colitis due to radiation depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Gastroenteritis and colitis due to radiation)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Plecanatide Improves Abdominal Bloating and Bowel Symptoms of Irritable Bowel: What a 1,436-Participant Study Found Plecanatide treatment improved IBS-C abdominal and bowel symptoms, including in those who present with moderate-to-severe bloating. Digestive diseases and sciences • 2024-05-15 • Phase III Randomized Trial | N = 1,436 | 96/100 | PMID 38594429 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of Acid Suppression Therapy on the safety and real-world benefits of Of the pooled intent-to-treat population, 338 of 2639 patients (12.8%) received concomitant acid suppression medication. Clinical therapeutics • 2022-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 35086735 ↗ |
Gastroenteritis and colitis due to radiation Patient Community & “People Like Me” Threads
Filter Gastroenteritis and colitis due to radiation community threads and patient logs by age, biological sex, dosage, and treatment duration.